ArticleOsteoarthritis and cartilage open2026
Arthroscopically and manually minced cartilage demonstrates lower cell viability and lower proteoglycan deposition compared to isolated chondrons and chondrocytes.
Article in Osteoarthritis and cartilage open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Autologous minced cartilage offers a single-stage, low-cost alternative to cell therapies for treatment of chondral defects. It is often derived from debrided defects or loose bodies, then minced for reimplantation. However, there is a paucity of knowledge on how mincing cartilage impacts viability and extracellular matrix deposition compared to quality-controlled cell therapies. The purpose is therefore to better characterize minced cartilage by comparing different mincing techniques to isolated cells. Methods: Cartilage samples were obtained from fresh human osteochondral allografts (JRF Ortho) and divided into: chondral allograft biopsy (control), manually minced cartilage, arthroscopically minced cartilage, isolated chondrons, and isolated chondrocytes. Samples were embedded in fibrin gels and cultured for 28 days. Staining for viability and histology for collagen and proteoglycan components were performed. Cartilage samples derived from debrided defects or loose bodies were evaluated for sulphated glycosaminoglycans (sGAGs), DNA, and wet weight. Results: At 28 days, viability of chondrons (93.7 ± 2.9%), chondrocytes (94 ± 22%) and manually minced cartilage (79.8 ± 16.2%) were significantly higher than arthroscopically minced cartilage (56.6 ± 15.4%). Over time, isolated cells showed proteoglycan and type II collagen deposition, while minced cartilage groups showed reduced proteoglycan content on histology. Clinical cartilage samples varied >10-fold in wet weight, total DNA, sGAGs/weight, and DNA/weight. Conclusion: This study showed isolated cells have consistently high viability and deposit more proteoglycans over time compared to both minced cartilage groups. Samples typically used for clinical application of minced cartilage can vary over 10-fold in cellularity and proteoglycan content. As consequences for treatment effect are unknown, implementation in clinical practice without quality regulation is not recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.